Phase 4 Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged between 18 and 70 years old.
• People whose breast cancer has been confirmed by laboratory testing to be invasive ductal carcinoma (a specific type of breast cancer).
• People whose breast cancer is classified as triple-negative breast cancer; if multiple areas of the breast are affected, all invasive areas must be triple-negative.
• People whose cancer either spread to nearby lymph nodes (confirmed after surgery), or whose cancer did not fully disappear after pre-surgery chemotherapy (at least four cycles completed, with some cancer still remaining in the breast or lymph nodes).
• People whose cancer has not come back locally or spread to other parts of the body.
• People who are enrolled either during their post-surgery treatment or within 60 days of finishing their last post-surgery treatment.
• People who are generally well enough to carry out daily activities with no more than minor limitations, as measured by a standard health scale (confirm with trial site).
• People whose liver and kidney function blood test results fall within acceptable ranges as defined by the trial (confirm with trial site).
• People whose blood cell counts — including white blood cells, platelets, and haemoglobin — meet the minimum levels required by the trial, without needing a recent blood transfusion (confirm with trial site).
• People who are willing to participate, are able to follow the study requirements, and have signed a consent form.

Who may not be able to join:

• People who have cancer in both breasts.
• People who have serious heart, liver, kidney, or hormonal system conditions that the trial doctors believe could create unacceptable health risks or affect participation in the study.
• People who have had another type of cancer in the past five years, other than certain treated skin cancers or early-stage cervical abnormalities.
• People who have a known allergy to Huaier granule (the treatment being studied).
• People who are pregnant, breastfeeding, or planning to become pregnant during the study period.
• People who are currently in another clinical trial, or who have taken part in another clinical study within the past three months.
• People who the trial doctors consider unsuitable for the study for other reasons, including concerns about ability to follow the study requirements.

Important: Always verify eligibility with the trial site directly before applying.